Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Virus Infection”

28,070 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28,070 results

Testing effectiveness (Phase 2)Study completedNCT00943540
What this trial is testing

Pharmacokinetic and Safety Study of Raltegravir and Atazanavir in a Once Daily Dose Regimen in HIV-1 Infected Patients

Who this might be right for
HIV InfectionHIV Infections
Radboud University Medical Center 20
Not applicableStudy completedNCT07267689
What this trial is testing

Evaluation of a Hypertonic Seawater Aerosol Therapy Solution in Adults and Children

Who this might be right for
Upper Resp Tract InfectionRhinitis AcuteRhinopharyngitis+2 more
Laboratoires Gilbert 110
Post-approval studies (Phase 4)Study completedNCT00129818
What this trial is testing

Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding

Who this might be right for
Genital Herpes
Novartis
Large-scale testing (Phase 3)Study completedNCT00197210
What this trial is testing

Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 10,708
Not applicableEnded earlyNCT05252910
What this trial is testing

Specimen Collection Study From Coronavirus Disease 2019 (COVID-19) Vaccinated Adults and Adolescents

Who this might be right for
COVID-19
Pharm-Olam, LLC 33
Testing effectiveness (Phase 2)Temporarily pausedNCT05150496
What this trial is testing

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 640
Not applicableLooking for participantsNCT05022446
What this trial is testing

The Impact of COVID-19 on Pulmonary Procedures

Who this might be right for
COVID-19 InfectionHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
M.D. Anderson Cancer Center 250
Testing effectiveness (Phase 2)Study completedNCT00040846
What this trial is testing

Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)+97 more
Fred Hutchinson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Testing effectiveness (Phase 2)Study completedNCT05954286
What this trial is testing

PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

Who this might be right for
SARS-CoV-2
Henry M. Jackson Foundation for the Advancement of Military Medicine 92
Not applicableStudy completedNCT04403386
What this trial is testing

Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19

Who this might be right for
COVID-19
National Institute of Environmental Health Sciences (NIEHS) 132
Large-scale testing (Phase 3)Study completedNCT04231968
What this trial is testing

AK0529 in Chinese Infants Hospitalized With RSV

Who this might be right for
Respiratory Syncytial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 311
Testing effectiveness (Phase 2)Ended earlyNCT05212818
What this trial is testing

Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults

Who this might be right for
COVID-19 Pneumonia
Techfields Inc 19
Testing effectiveness (Phase 2)Study completedNCT01067690
What this trial is testing

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Who this might be right for
Kaposi's Sarcoma
Barbara Ensoli, MD, PhD 25
Very early researchStudy completedNCT03421613
What this trial is testing

3VM1001 Cream for the Treatment of Pain Associated With Post Herpetic Neuralgia (PHN)

Who this might be right for
Treatment of PHN
CDA Research Group, Inc. 28
Early research (Phase 1)Study completedNCT02295813
What this trial is testing

Safety and Pharmacokinetics Study of FBF001

Who this might be right for
Avian Influenza
Fab'entech 16
Large-scale testing (Phase 3)Study completedNCT00710060
What this trial is testing

Effectiveness of a Community-level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-risk Populations

Who this might be right for
HIV InfectionsSexually Transmitted Diseases
RTI International 18,147
Early research (Phase 1)Study completedNCT00001020
What this trial is testing

A Phase I Study of the Safety and Immunogenicity of rgp120/HIV-1IIIB Vaccine in Healthy Adult Subjects (NOTE: Study Extended ONLY for Subjects Who Have Previously Received rgp120/HIV-1IIIB or rgp120/HIV-1MN on VEU 006 or VEU 006 Rollover Study)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Large-scale testing (Phase 3)Study completedNCT05595824
What this trial is testing

Open Multicenter Study for Assessment of Efficacy and Safety of Molnupiravir in Adult Patients With COVID-19

Who this might be right for
COVID-19
Promomed, LLC 240
Early research (Phase 1)Study completedNCT00902824
What this trial is testing

Safety and Immunogenicity of TBC-M4, a MVA HIV Vaccine Alone or in a Prime-Boost Regimen With ADVAX DNA HIV Vaccine

Who this might be right for
HIV Infections
International AIDS Vaccine Initiative 32
Next Page